tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Atara Biotherapeutics Reduces Board Size, Appoints New Chair

Story Highlights
Atara Biotherapeutics Reduces Board Size, Appoints New Chair

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Atara Biotherapeutics ( (ATRA) ) has issued an update.

On September 2, 2025, Atara Biotherapeutics announced a strategic reduction in its Board of Directors from ten to seven members to better align with its current operations and the boards of similar-sized public companies. This decision led to the voluntary resignation of directors Ameet Mallik, Pascal Touchon, and Maria Grazia Roncarolo, M.D., with Gregory A. Ciongoli being appointed as the new Chair of the Board, replacing Pascal Touchon.

The most recent analyst rating on (ATRA) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Atara Biotherapeutics stock, see the ATRA Stock Forecast page.

Spark’s Take on ATRA Stock

According to Spark, TipRanks’ AI Analyst, ATRA is a Neutral.

Atara Biotherapeutics’ overall stock score reflects significant financial challenges, with negative equity and cash flow issues being major concerns. However, technical indicators show some positive momentum, and recent corporate events suggest potential future growth opportunities. The valuation remains a cautionary factor due to current financial instability.

To see Spark’s full report on ATRA stock, click here.

More about Atara Biotherapeutics

Atara Biotherapeutics, Inc. is a Delaware-based company operating in the biotherapeutics industry, focusing on developing transformative therapies for patients with serious diseases.

Average Trading Volume: 53,637

Technical Sentiment Signal: Hold

Current Market Cap: $86.66M

See more data about ATRA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1